These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 17499950)

  • 41. Choosing the right laboratory: a review of clinical and forensic toxicology services for urine drug testing in pain management.
    Reisfield GM; Goldberger BA; Bertholf RL
    J Opioid Manag; 2015; 11(1):37-44. PubMed ID: 25750163
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Mycobacterial tests].
    Takashima T; Higuchi T
    Kekkaku; 2008 Jan; 83(1):43-59. PubMed ID: 18283915
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changing media in workplace programs.
    Lappe ML
    Occup Health Saf; 2002 Apr; 71(4):28-32. PubMed ID: 11977559
    [No Abstract]   [Full Text] [Related]  

  • 44. Workplace urine screening for drug abuse.
    Wright DS
    J Med Ethics; 1997 Jun; 23(3):191. PubMed ID: 9220335
    [No Abstract]   [Full Text] [Related]  

  • 45. Special report. Drug testing in the workplace: an update.
    Hosp Secur Saf Manage; 1994 Oct; 15(6):5-9. PubMed ID: 10137771
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Procedures for transportation workplace drug and alcohol testing programs. Final rule.
    Office of the Secretary, DOT
    Fed Regist; 2008 Jun; 73(123):35961-75. PubMed ID: 18677826
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug testing. Balancing privacy and public safety.
    DeCew JW
    Hastings Cent Rep; 1994; 24(2):17-23. PubMed ID: 8026932
    [No Abstract]   [Full Text] [Related]  

  • 48. The medical review officer: a potential role for the medical examiner.
    Sgan SL; Hanzlick R
    Am J Forensic Med Pathol; 2003 Dec; 24(4):346-50. PubMed ID: 14634473
    [TBL] [Abstract][Full Text] [Related]  

  • 49. European guidelines for quality assurance in cervical cancer screening: recommendations for cytology laboratories.
    Wiener HG; Klinkhamer P; Schenck U; Arbyn M; Bulten J; Bergeron C; Herbert A
    Cytopathology; 2007 Apr; 18(2):67-78. PubMed ID: 17397490
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mandatory drug testing: boon for public safety or launch of a witch-hunt?
    Sutherland R
    CMAJ; 1992 Apr; 146(7):1215-20. PubMed ID: 1285735
    [No Abstract]   [Full Text] [Related]  

  • 51. Health care organization drug testing.
    Brooks JP; Dempsey J
    Health Care Superv; 1992 Sep; 11(1):11-5. PubMed ID: 10120030
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The medical review officer and workplace drug testing.
    Clark HW
    J Psychoactive Drugs; 1990; 22(4):435-45. PubMed ID: 2096188
    [TBL] [Abstract][Full Text] [Related]  

  • 53. World Health Organization/HIVResNet Drug Resistance Laboratory Strategy.
    Bertagnolio S; Derdelinckx I; Parker M; Fitzgibbon J; Fleury H; Peeters M; Schuurman R; Pillay D; Morris L; Tanuri A; Gershy-Damet GM; Nkengasong J; Gilks CF; Sutherland D; Sandstrom P
    Antivir Ther; 2008; 13 Suppl 2():49-57. PubMed ID: 18575191
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Legal issues facing physicians: substance abuse in the workplace.
    Clark HW; Johnson B
    Occup Med; 2002; 17(1):119-35, v. PubMed ID: 11726341
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Random drug testing: a commitment to a drug free workplace.
    Smith NG
    AAOHN J; 1993 Apr; 41(4):193-4. PubMed ID: 8507286
    [No Abstract]   [Full Text] [Related]  

  • 56. Industrial employee drug screening: a blind study of laboratory performance using commercially prepared controls.
    Knight SJ; Freedman T; Puskas A; Martel PA; O'Donnell CM
    J Occup Med; 1990 Aug; 32(8):715-21. PubMed ID: 2401928
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Current status of accreditation for drug testing in hair.
    ; Cooper G; Moeller M; Kronstrand R
    Forensic Sci Int; 2008 Mar; 176(1):9-12. PubMed ID: 18024039
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Keys to a successful program.
    Kerns DL; Stopperan WI
    Occup Health Saf; 2000 Oct; 69(10):230, 232-4. PubMed ID: 11056928
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A guide to NIDA certification for workplace drug testing.
    Armbruster DA
    MLO Med Lab Obs; 1992 Feb; 24(2):31-2, 34, 36. PubMed ID: 10171052
    [No Abstract]   [Full Text] [Related]  

  • 60. Present and future opportunities.
    Kenney JE
    Occup Health Saf; 2005 Aug; 74(8):84, 86. PubMed ID: 16212029
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.